Your actions make a difference. Take a stand for the future of medicine.
We can’t advance patient-centered innovation alone. Join us in our fight to protect patient access to medications and treatments and support the next generation of medical breakthroughs.
Policymakers are discussing a misguided drug pricing plan—known as “Most Favored Nation” price setting —that would tie the cost of medicines in the U.S. to prices that other countries pay. It sounds like a quick fix, but it actually won’t guarantee lower out-of-pocket costs for patients—and it comes with serious risks.
A few years ago, Congress passed the Inflation Reduction Act, which included a harmful policy that threatens access to essential treatments. This policy, known as the “pill penalty” unfairly targets medicines that typically come in pill form—like capsules and tablets—by making them eligible for government price setting years before other kinds of medicines.
We need your help to keep up the pressure on Congress to pass strong PBM reform this year. Just three PBMs control 80% of the market. They rely on opaque business practices that experts warn can lead to higher costs for patients.
